Evidence map›Paper›PMID 41781161›Full record

ArticleRMD open2026

[

Donghe Chen, Danqing Huang, Chuanyin Sun, Zhenfeng Liu, Danhua Zhu, Kui Zhao, Xinhui Su

Abstract read
In one paragraph

Article in RMD open, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Donghe Chen *Department of Nuclear Medicine, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang, China.ORCID 0000-0003-3388-7907
Danqing Huang *Department of Rheumatology, Pujiang branch of the First Affiliated Hospital of Zhejiang University, Jinhua, Zhejiang, China.ORCID 0009-0000-9672-5521
Chuanyin SunDepartment of Rheumatology, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang, China.ORCID 0000-0003-1735-0966
Zhenfeng LiuDepartment of Nuclear Medicine, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang, China.ORCID 0009-0001-2398-2014
Danhua ZhuState Key Laboratory for Diagnosis and Treatment of Infectious Diseases, Hangzhou, Zhejiang, China.ORCID 0000-0001-8940-0681
Kui ZhaoDepartment of Nuclear Medicine, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang, China.ORCID 0009-0005-2353-1896
Xinhui SuDepartment of Nuclear Medicine, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang, China suxinhui@zju.edu.cn.ORCID 0000-0002-4782-3982

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundPURPOSE: To establish organ-specific reference thresholds for IgG4-RD involvement on [

methodsThis retrospective study recruited 85 patients with IgG4-RD and 10 healthy individuals, all of whom underwent [

resultsAmong 85 patients with IgG4-RD, 64 lesions suspected of IgG4-RD involvement were biopsied and 58 (90.6%) of these lesions were positive for IgG4. [

conclusion[

Indexed as

Immunoglobulin G4-Related DiseasePositron Emission Tomography Computed TomographyAdultAgedFemaleFibroblast Activation Protein AlphaHumansMaleMiddle AgedRetrospective StudiesROC CurveFibroblast Activation Protein AlphaAutoimmune DiseasesDisease ActivityInflammation

Identifiers

PMID41781161
PMCPMC12970091

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.